Drug interactions
Ipratropium-salbutamol + Oxybutynin transdermal
Severity: Minor
Ipratropium-salbutamol and Oxybutynin transdermal: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oxybutynin is an antimuscarinic and ipratropium has the same action. Additive anticholinergic effects such as dry mouth, constipation and urinary retention are possible, but transdermal oxybutynin and inhaled ipratropium both give limited systemic exposure.
What this interaction means in plain words
Ipratropium-salbutamol and Oxybutynin transdermal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Additive muscarinic receptor blockade with low systemic exposure.
What to do
No routine change is needed. Ask about anticholinergic symptoms, particularly in older adults on several anticholinergic drugs.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Oxybutynin transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Frequently asked questions
Can I take Ipratropium-salbutamol with Oxybutynin transdermal?
MediHelp rates the interaction as minor. Ipratropium-salbutamol and Oxybutynin transdermal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Oxybutynin is an antimuscarinic and ipratropium has the same action. Additive anticholinergic effects such as dry mouth, constipation and urinary retention are possible, but transdermal oxybutynin and inhaled ipratropium both give limited systemic exposure.
How serious is the interaction between Ipratropium-salbutamol and Oxybutynin transdermal?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed. Ask about anticholinergic symptoms, particularly in older adults on several anticholinergic drugs.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
